Depending upon the pricing structure & availability of Saxagliptin (Onglyza) the pill should do well in India, as India happens to be perhaps the capital of diabetics.
India is the perhaps the first Asian country where saxagliptin is available, launched by Bristol-Myers Squibb and AstraZeneca.
- Onglyza Information for Consumers
- Onglyza Information for Healthcare Professionals (includes dosage details)
- Side Effects of Onglyza (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 15 Oct 2009 • 1 answer
Posted 8 Sep 2010 • 2 answers
Posted 9 Mar 2011 • 6 answers
Posted 23 Jul 2011 • 1 answer
Posted 9 May 2012 • 1 answer